Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Total non-GAAP adjustments to costs and expenses by Quarter
Total non-GAAP adjustments to costs and expenses ($M) ($M)
Gilead Sciences Total non-GAAP adjustments to costs and expenses: $3,065M in Q2 2026, up 275.2% from a year earlier.
Where the Q2 2026 figure comes from
“|| Total non-GAAP adjustments to costs and expenses | 3,065 | 817 | 3,746 | 1,472”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K Non-GAAP Adjustment Summary.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Gilead Sciences Total non-GAAP adjustments to costs and expenses ($M), quarterly Q1 2022–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-opex
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.